ExperimentalPre-clinical

RgIA

alpha-Conotoxin RgIA from Conus regius venom

13 Amino Acids · MW: 1,670 Da

Amino Acids

13

Molecular Weight

1,670 Da

Half-life

Minutes to hours

Research Score

4.8

Studies

130

Storage

Store lyophilized at -20°C, reconstituted at 2-8°C

What is RgIA?

RgIA is a disulfide-rich cone snail peptide that selectively antagonizes the alpha9alpha10 nicotinic acetylcholine receptor. It is used as a research tool in pain and neuroimmune signaling studies and as a pre-clinical analgesic lead.

Key Benefits & Mechanisms

alpha9alpha10 nAChR selectivity

neuropathic pain model tool

neuroimmune signaling research

analgesic lead discovery

Research Summary

Scientific studies show RgIA can strongly inhibit alpha9alpha10 nicotinic signaling with high selectivity compared with many other nAChR ligands. It is widely used to probe peripheral sensory pathways and inflammation-linked pain mechanisms.